Recruiting NA INTERVENTIONAL 2-arm NCT04434586

Contribution of Optical Coherence Tomography in the Endovascular Treatment of Femoral Occlusions (TOCAF)

Sponsor: Abbott

Conditions Claudication Ischemic Leg Superficial Femoral Artery Stenosis

Interventions femoropopliteal revascularization for TASC C or TASC D lesion

Updated 8 times since 2020 Last updated: Dec 16, 2025 Started: Jun 16, 2020 Primary completion: Jun 30, 2026 Completion: Jun 30, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Claudication and Ischemic Leg, this trial is actively recruiting participants. The trial is conducted by Abbott and has accumulated 8 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Jan 2026 — Present [monthly]

Recruiting NA

Status: Unknown → Recruiting
Sep 2024 — Jan 2026 [monthly]

Unknown NA
Aug 2024 — Sep 2024 [monthly]

Unknown NA

Status: Recruiting → Unknown
Jul 2024 — Aug 2024 [monthly]

Recruiting NA
Jun 2022 — Jul 2024 [monthly]

Recruiting NA

▶ Show 3 earlier versions

Jan 2021 — Jun 2022 [monthly]

Recruiting NA
Sep 2020 — Jan 2021 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jul 2020 — Sep 2020 [monthly]

Not Yet Recruiting NA

First recorded

Jun 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abbott
University Hospital, Lille

Data source: University Hospital, Lille

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lille, France